Antidemenia Agents are Partially Symptomatic Treatment and Partially Disease Modifying Treatment
説明
Antidementia agents, i.e., cholinesterase inhibitors (ChEIs) and N-methyl-D-aspartate (NMDA) receptor (NMDA-R) antagonist are now considered to be symptomatic treatment. However, ChEIs and NMDA-R antagonist are proven to have neuroprotecting actions against amyloid pathology
収録刊行物
-
- Brain Disorders & Therapy
-
Brain Disorders & Therapy 04 2015-01-01
OMICS Publishing Group
